Impact of Continuing Medical Education (CME) Insulin Program
Impact of CME Program on Self-Reported Confidence and Use of Insulin in Persons With Type 2 Diabetes
1 other identifier
observational
294
1 country
1
Brief Summary
The purpose of this study is to determine if a continuing medical education (CME) program can change primary care providers' use of insulin therapy - their confidence in selecting doses and engagement of patients in the decision making as to whether to initiate insulin therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 15, 2009
CompletedFirst Posted
Study publicly available on registry
January 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedDecember 2, 2015
August 1, 2013
3.2 years
January 15, 2009
November 30, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
We will determine whether attendees' self-reported confidence and use of insulin with persons with type 2 diabetes changes after they attend the CME program.
pre program survey & 2-4 month post program survey
Secondary Outcomes (1)
pre-CME training level of patient's A1c when starting insulin therapy compared to post-CME training level of patient's A1c when starting insulin therapy
pre program survey and 2-4 month post program survey
Study Arms (1)
primary care provider
attending insulin CME Training
Eligibility Criteria
Primary care providers affiliated with the participating healthcare organizations were invited to attend.
You may qualify if:
- primary care provider attending CME training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HealthPartners Institutelead
- International Diabetes Center at Park Nicolletcollaborator
- Eli Lilly and Companycollaborator
- Novo Nordisk A/Scollaborator
- United Health Carecollaborator
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
International Diabetes Center
Minneapolis, Minnesota, 55416, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret Powers, PhD
International Diabetes Center at Park Nicollet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2009
First Posted
January 19, 2009
Study Start
June 1, 2006
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
December 2, 2015
Record last verified: 2013-08